MAPT and Alzheimer disease: While each of these features is associated with AD progression, post-mortem histological data and PET imaging studies showed a high degree of correlation between cognitive decline and NFT as opposed to amyloid burden1–4 and the co-localization of tau pathology with neuronal degeneration.